PMU75 - IS ADOPTING A LOW PRICE STRATEGY TO GAIN MARKET ACCESS COMPATIBLE WITH A VIABLE GENE/CELL THERAPY BUSINESS?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1911
https://www.valueinhealthjournal.com/article/S1098-3015(18)35213-6/fulltext
Title :
PMU75 - IS ADOPTING A LOW PRICE STRATEGY TO GAIN MARKET ACCESS COMPATIBLE WITH A VIABLE GENE/CELL THERAPY BUSINESS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35213-6&doi=10.1016/j.jval.2018.09.1911
First page :
Section Title :
Open access? :
No
Section Order :
1277